Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Illumina Laboratory Services, |
RCV000328472 | SCV000375449 | benign | Mucolipidosis type II | 2018-01-13 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. |
Illumina Laboratory Services, |
RCV000380692 | SCV000375450 | benign | Pseudo-Hurler polydystrophy | 2018-01-13 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000587904 | SCV000699477 | benign | not provided | 2016-10-10 | criteria provided, single submitter | clinical testing | Variant summary: The GNPTAB c.204-15G>T variant involves the alteration of a non-conserved intronic nucleotide. Mutation taster predicts a benign outcome for this variant along with 5/5 splice prediction tools predict no significant impact on splicing. This variant was found in 5864/121394 control chromosomes (675 homozygotes), predominantly observed in the East Asian subpopulation at a frequency of 0.3188339 (2756/8644). This frequency greatly exceeds the estimated maximal expected allele frequency of a pathogenic GNPTAB variant (0.0022361), indicating this is a benign polymorphism found primarily in the populations of East Asian origin. The variant of interest has not, to our knowledge, been reported in affected individuals via publications nor evaluated for functional impact by in vivo/vitro studies. One reputable clinical lab has classified the variant as benign. Taken together, this variant is classified as benign. |
Gene |
RCV000587904 | SCV000975317 | benign | not provided | 2018-06-19 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Labcorp Genetics |
RCV001518439 | SCV001727130 | benign | Mucolipidosis type II; Pseudo-Hurler polydystrophy | 2025-01-28 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV000328472 | SCV001749159 | benign | Mucolipidosis type II | 2021-07-01 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV000380692 | SCV001749160 | benign | Pseudo-Hurler polydystrophy | 2021-07-01 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV000587904 | SCV005235019 | benign | not provided | criteria provided, single submitter | not provided | ||
Mayo Clinic Laboratories, |
RCV000587904 | SCV000800959 | benign | not provided | 2017-12-06 | no assertion criteria provided | clinical testing |